SCHEMBL5829620

SCHEMBL5829620

c1ccc([AsH]c2ncnc3nc[nH]c23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 2/20 0.48
DBF4 Q9UBU7 2/20 0.48
EGFR P00533 1/20 0.48
CSF1R P07333 1/20 0.48
LMNA P02545 6/20 0.47
TSHR P16473 3/20 0.47
MAPK1 P28482 2/20 0.47
CYP1A2 P05177 2/20 0.47
CDK2 P24941 2/20 0.47
CYP2D6 P10635 1/20 0.47
HTT P42858 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
HSD17B10 Q99714 3/20 0.44
PI4KA P42356 2/20 0.44
PI4K2B Q8TCG2 2/20 0.44
PI4K2A Q9BTU6 2/20 0.44
PI4KB Q9UBF8 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LRRK2 Q5S007 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1081384 0.76 CDC7 (0.55) CDC7DBF4EGFRCSF1RLMNA
SCHEMBL5829618 0.73 JAK2 (0.33) LMNATSHRMAPK1CYP1A2CDK2
SCHEMBL2938675 0.70 AKT2 (0.70) CDC7DBF4EGFRCSF1RAKT2
SCHEMBL5998976 0.68 HIF1A (0.48) CDC7DBF4EGFRCSF1RLMNA
SCHEMBL1060507 0.67 MKNK1 (0.72) EGFRLMNATSHRMAPK1CYP1A2
SCHEMBL796398 0.67 CDC7 (0.72) CDC7DBF4EGFRCSF1RLMNA
SCHEMBL29001527 0.67 CDC7 (0.48) CDC7DBF4EGFRCSF1RLMNA
SCHEMBL5384434 0.67 CDC7 (0.59) CDC7DBF4EGFRCSF1RLMNA
SCHEMBL5808903 0.66 SMN1; SMN2 (0.57) CDC7DBF4EGFRCSF1RLMNA
SCHEMBL8707168 0.66 LMNA (0.62) CDC7DBF4EGFRCSF1RLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673439-A2 METHODS FOR ALTERING MRNA SPLICING AND TREATING FAMILIAL DYSAUTONOMIA AND OTHER MECHANISTICALLY RELATED DISORDERS THE GENERAL HOSPITAL CORPORATION (US) 2006-06-28 EP disclosed
WO-2005033290-A2 METHODS FOR ALTERING MRNA SPLICING AND TREATING FAMILIAL DYSAUTONOMIA AND OTHER MECHANISTICALLY RELATED DISORDERS THE GENERAL HOSPITAL CORPORATION (US) 2005-04-14 WO disclosed